Belite Bio Inc (BLTE) Statistics & Valuation Metrics - Stocknear

Belite Bio Inc

NASDAQ: BLTE · Real-Time Price · USD
65.68
-1.83 (-2.71%)
At close: Sep 09, 2025, 3:59 PM
65.68
0.00%
After-hours: Sep 09, 2025, 04:04 PM EDT

Belite Bio Inc Statistics

Share Statistics

Belite Bio Inc has 32.6M shares outstanding. The number of shares has increased by 6.31% in one year.

32.6M
6.31%
2.26%
0.48%
15.17M
629
1.23%

Short Selling Information

The latest short interest is 189.11K, so 0.58% of the outstanding shares have been sold short.

189.11K
0.58%
1.24%
3.17

Valuation Ratios

The PE ratio is -53.31 and the forward PE ratio is -39.13. Belite Bio Inc's PEG ratio is 63.44.

-53.31
-39.13
0
88
13.21
-65.58
63.44
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Belite Bio Inc.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.

24.31
24.31
0
-0.02
-0.02
-1999.8

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.45M
25
0
n/a

Taxes

6K
-0.02%

Stock Price Statistics

The stock price has increased by 38.14% in the last 52 weeks. The beta is -1.5, so Belite Bio Inc's price volatility has been lower than the market average.

-1.5
38.14%
63.98
62.53
56.1
50,967

Income Statement

n/a
-449K
-40M
-36.14M
-35.67M
-36.12M
-1.18
Full Income Statement

Balance Sheet

The company has 31.68M in cash and 537K in debt, giving a net cash position of 31.14M.

31.68M
537K
31.14M
-107.65M
164.2M
153.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -29.23M and capital expenditures -151K, giving a free cash flow of -29.39M.

-29.23M
-151K
-29.39M
-0.96
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

BLTE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BLTE is $100, which is 48.1% higher than the current price. The consensus rating is "Buy".

$100
48.1%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

201.04
1